EGFR and non-small cell lung carcinoma: The results showed that in The Cancer Genome Atlas (TCGA)-NSCLC database, FAK was not related to OS, but in our NSCLC patients receiving EGFR-TKI cohort, high FAK expression indicated poor prognosis; resistant cells likewise showed FAK upregulation, and FAK was identified as a resistance “hub” gene.